VetCell Therapeutics USA
  • Menu
    • About Us
      • Our Story
      • Meet the Team
      • Our Facilities
      • Our Technologies
    • Why Stem Cells?
      • Stem Cells 101
      • Autologous vs. Allogenic
    • Moving Forward
      • On-going Trials
      • Press & Publications
      • Research Collaborations
  • MSC Products
  • Connect With Us
  • Blog
Select Page
VetCell Therapeutics Presenting Canine Allogenic MSC Study Results and Unveiling Cell Therapy Extended Shipping Solution at NAVRMA 2019

VetCell Therapeutics Presenting Canine Allogenic MSC Study Results and Unveiling Cell Therapy Extended Shipping Solution at NAVRMA 2019

by Michael Farino | Sep 5, 2019 | Press Releases

SANTA ANA, Calif., September 5, 2019–VetCell Therapeutics USA, a pet-focused cell therapy division of PrimeGen Global, Inc., announced today that the company will be presenting multiple presentations at the North American Veterinary Regenerative Medicine Association’s...
VetCell Therapeutics and Western University Seek Allogeneic Stem Cell Treatment for Canine Atopic Dermatitis

VetCell Therapeutics and Western University Seek Allogeneic Stem Cell Treatment for Canine Atopic Dermatitis

by Michael Farino | Nov 8, 2017 | Press Releases

PRESS RELEASE FOR IMMEDIATE RELEASE                                    VetCell Therapeutics and Western University Seek Allogeneic Stem Cell Treatment for Canine Atopic Dermatitis The two parties will collaboratively study the efficacy and safety of treating canine...
PrimeGen Biotech Creates VetCell Therapeutics Subsidiary

PrimeGen Biotech Creates VetCell Therapeutics Subsidiary

by Michael Farino | Apr 24, 2015 | Press Releases

PrimeGen Biotech Creates VetCell Therapeutics Subsidiary – Prioritizes Deployment of Cell Therapies for Improving Quality of Life of Pets Living with Degenerative Diseases   VetCell to Offer Advanced Therapies Utilizing Allogeneic and Autologous Stem Cells Derived...